Actively building life science companies

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.

Scroll to experience 5AM Ventures

Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.

Read Me

Cidara Therapeutics Named a San Diego Metro Area Top Workplace for Second Consecutive Year
Read Me

Crinetics Pharmaceuticals Reports Third Quarter 2018 Financial Results
Read Me

Homology Medicines Reports Third Quarter 2018 Financial Results
Read Me

5AM Welcomes New Team Members: Partner Deborah Palestrant, Venture Partner Elliot Ehrich, General Counsel Galya Blachman
Read Me

Cabaletta Bio Emerges Out of University of Pennsylvania to Develop CAAR T Cell Technology to Treat B Cell-mediated Autoimmune Diseases

Pushing the healthcare industry forward

$ 1 B

UNDER MANAGEMENT

We’re a life science venture capital firm founded in 2002 and currently investing $285M from our fifth fund.
71

PORTFOLIO COMPANIES

Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.
35

ONGOING CLINICAL TRIALS

Our portfolio companies currently have over 18,000 patients enrolled across 750 test sites in ongoing clinical trials.

San Francisco, CA

Boston, MA